Sequencial Treatment Plan using Triphala for Eczema

Development of an Algorithm for Triphala in the management of Eczema through clinical assessment - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081011

Enrollment

Registered

2025-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient who fulfil eczema criteria of American Academy of Dermatology. Patient having eczema minimum 5 months to maximum 15 years.

Exclusion criteria

Exclusion criteria: Patients other than inclusion criteria Known case of Disease like D.M, Cancer, AIDS, STD, TB, Renal failure, heart disease and other disorders which lead to fatal condition during Virechana Karma. Pregnant and lactating women Patients with Srava and Paka (For Group-B)

Design outcomes

Primary

Measure	Time frame
To develop suitable, accurate and user-friendly Algorithm for Triphala in the management of EczemaTimepoint: 6 weeks	—

Secondary

Measure	Time frame
1.To conduct a literary review on Triphala and eczema for clinical applications. 2.To conduct Pharmacognostical and analytical study of Triphala. 3.To conduct a Clinical assessment of two different clinical plans (sequences) of Triphala in the management of Eczema. Timepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDr Ketki Aurangabadkar

Government Ayurved college and Hospital, Vadodara

drdilipjn@gmail.com9925941861

Outcome results